GSK settles lawsuit over heartburn drug Zantac with alleged cancer links but ‘admits no liability’ June 23, 2023 Pharmaceutical giant GSK has revealed it has settled a lawsuit relating to discontinued heartburn drug Zantac, which was alleged to be linked to cancer. Shares in GSK jumped after it said an upcoming trial was cancelled but that it does not admit liability. The company hit back at allegations last year that the use of [...]
GSK offloads £804m worth of shares in spun out healthcare arm Haleon May 12, 2023 British drugmaker GlaxoSmithKline (GSK) has today offloaded some 240m shares of its spun out consumer healthcare group Haleon in a move which has raised £804m for the firm.
Haleon: Flu season and Chinese pain relief give GSK spin-out a boost May 3, 2023 A “strong” cold and flu season and the end of Chinese lockdowns contributed to a healthy revenue boost for Haleon, the spin-out of GSK’s consumer healthcare division. Organic revenues within the group were up 9.9 per cent, with operating profit hitting £627m – reflecting a large reduction in the costs of spinning out the business [...]
GSK brings in zosta lot more cash as drugs giant’s turnover boosted by shingles vaccine and HIV medicines April 26, 2023 Drugs giant GSK has posted better-than-forecast revenues for the first quarter thanks to strong sales of its shingles vaccine and HIV medicines. The FTSE 100 group saw earnings fall 15 per cent on a constant currency basis to £2.1bn in the first quarter as revenues dropped eight per cent to £7bn after sales of its Covid-19 treatment [...]
GSK: Hundreds of workers at British pharma giant to strike in May in pay dispute April 19, 2023 Hundreds of workers at pharmaceutical giant GSK will stage a series of walkouts in May in a dispute over pay. Unite said 750 of its members have voted for strike action after rejecting a 6% pay offer and a one-off lump sum of £1,300, describing it as “significantly below” inflation. Unite said industrial action will [...]
GSK coughs up £1.6bn for Bellus as pharma giant boosts its patent medicine cabinet April 18, 2023 GSK plans to buy developer Bellus Health in an all-cash deal for £1.6bn as the drugmaker expands its bet on respiratory therapies.
Shingles vaccine gives GSK a shot in the arm – as Haleon demerger nets £10.1bn gain February 1, 2023 Pharma giant GSK recorded what Dame Emma Walmsley called a "landmark" year with vaccine sales driven up significantly
GSK and Sanofi shares jump with investor fears soothed by Zantac ruling December 7, 2022 Shares in GlaxoSmithKline (GSK) and Sanofi jumped today, after thousands of claims apart of the Zantac lawsuit were dismissed. Investors’ fears were soothed yesterday when US district judge Robin Rosenberg rejected 50,000 claims in federal court for not being based on sound science. GSK’s shares jumped around eight per cent to 1,498.00p per share in [...]
GSK makes headway with two cancer drugs after double-barrelled setback last month December 2, 2022 GlaxoSmithKline (GSK) is making “significant” headway with two of its cancer drugs, following a double-barrelled setback in its oncology efforts last month. The British pharmaceutical giant’s bone marrow cancer treatment Momelotinib this morning received marketing approval from the European Medicines Agency, following an application to the FDA in the US in August. If approved by [...]
Citi and Morgan Stanley cut price targets for GSK following weeks of setbacks December 1, 2022 GlaxoSmithKline (GSK) has rattled the faith of two of the world’s biggest banks, which cut their share price forecasts for the British pharmaceutical giant this week. The London-listed pharma firm faced a double-barrelled setback to its oncology efforts in November, which has put banks and investors on more cautious footing. Citigroup earlier today slashed [...]